Dosar de subiect
Merck Acquires Terns for $6.7 Billion to Expand Cancer Portfolio
Primul articol: 25 mar. 2026, 20:54
|
Ultima actualizare: 25 mar. 2026, 20:54
|
1 sursa
|
1 articol
Mai multe surse. Mai putina manipulare.
Analiza editoriala
Bazat pe 1 sursa, 1 articol
Merck, a major pharmaceutical company, has announced its acquisition of Terns Pharmaceuticals for $6.7 billion. This strategic move is intended to strengthen Merck's position in the rapidly evolving field of blood cancer treatments. Terns Pharmaceuticals has been developing innovative therapies targeting various forms of blood cancer.Articole despre acest subiect
Foto: The Independent
Avalanche in Swedish ski resort leaves multiple people trapped
The incident prompted a significant emergency services response, including assistance from Norway
Citeste pe The Independent →